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Abstract
The ability of a cancer cell to migrate through the dense extracellular matrix (ECM) within and 
surrounding the solid tumor is a critical determinant of metastasis. Macrophages enhance invasion 
and metastasis in the tumor microenvironment but the basis for their effects are not fully 
understood. Using a microfluidic 3D cell migration assay, we found that the presence of 
macrophages enhanced the speed and persistence of cancer cell migration through a 3D 
extracellular matrix in a matrix metalloproteinases (MMP)-dependent fashion. Mechanistic 
investigations revealed that macrophage-released TNFα and TGFβ1 mediated the observed 
behaviors by two distinct pathways. These factors synergistically enhanced migration persistence 
through a synergistic induction of NF-κB-dependent MMP1 expression in cancer cells. In contrast, 
macrophage-released TGFβ1 enhanced migration speed primarily by inducing MT1-MMP 
expression. Taken together, our results reveal new insights into how macrophages enhance cancer 
cell metastasis, and they identify TNFα and TGFβ1 dual blockade as an anti-metastatic strategy in 
solid tumors.
Introduction
Cancer cells are surrounded by a complex tumor microenvironment consisting of 
extracellular matrix (ECM), tumor-associated stromal cells, and a myriad of signaling 
molecules (1), which can significantly influence tumor growth and metastasis (2). ECM in 
the tumor microenvironment acts as a barrier to metastasis, and cancer cells have enhanced 
capabilities to navigate through the dense 3D collagen ECM surrounding the tumor (3). To 
migrate through the ECM, cancer cells employ proteases such as matrix metalloproteinases 
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(MMPs) to degrade ECM, kinases to assist in forming protrusions, and integrins to adhere to 
the matrix to enable movement (4). Indeed, the activities and/or expressions of these 
molecules have been shown to be elevated in cancer cells (5–7).
Macrophages, one of the most abundant stromal cell types in the tumor microenvironment, 
are key promoters of tumor metastasis (8). Various clinical data have revealed that the 
infiltration of macrophages in tumor tissues correlates with poor prognosis in cases of breast 
cancer, prostate cancer, and melanoma (9,10). Moreover, in vivo and in vitro studies have 
shown that macrophages enhance cancer cell intravasation (11,12) and invasion through 
various signaling pathways (13,14). However, many of these in vitro migration studies were 
performed on 2D tissue culture substrates, which fail to capture the 3D microenvironment 
present in vivo. In addition, the majority of these studies were carried out using transwell 
assays, which only yield an end-point readout of cell behaviors (15) and thereby provide 
little information on how macrophages affect different aspects of cancer cell migration, such 
as how fast or how persistently the cancer cell moves. These distinct features of migration 
(speed vs. persistence) describe cell migration dynamics, and they can be quantified using 
metrics such as total speed and directedness. Total speed (the total distance that cell 
migrated divided by the migration time) defines how fast a cancer cell migrates. In contrast, 
directedness (the ratio of cell displacement to the total distance that the cell travelled) 
measures the persistence of the cell movement (15,16).
Recently, it has become increasingly clear that both migration speed and persistence 
determine the metastatic potential of a cancer cell (17), and stimuli that increase both of 
these factors can greatly enhance metastasis. More importantly, speed and persistence can be 
modulated independently of one another by a single stimulus. For example, inhibiting 
integrin has been shown to decrease cancer cell migration speed but has no effect on 
persistence (17). On the other hand, interstitial flow can increase cancer cell migration 
persistence without altering the speed of migration (18). Lending further complexity, a 
stimulus can affect speed and persistence of migration differently when cells are cultured on 
2D substrates compared to in 3D matrix. Specifically, EGF has been shown to increase 
cancer cell migration speed and decrease persistence when cells are migrating on 2D 
surfaces. However, this same growth factor enhances both cancer cell migration speed and 
persistence when cells are cultured in 3D ECM (19). Collectively, these results highlight the 
importance of characterizing how a stimulus affects different aspects of cancer cell 
migration (i.e. speed and persistence) in 3D ECM to gain a detailed and quantitative 
understanding of metastasis. However, to our knowledge, the effects of macrophages on the 
dynamics (speed and persistence) of cancer cell migration in 3D ECM have not been 
explored.
In the present study, we employed a microfluidic 3D migration assay to examine how 
macrophages affect different aspects (speed and persistence) of cancer cell migration. This 
microfluidic assay allows us to perform real-time high-resolution imaging of cancer cells 
migrating in 3D collagen I ECM in the presence of macrophages, which recapitulates key 
aspects of their interactions in the primary tumor sites in vivo. By tracking the movement of 
cancer cells within the 3D ECM, we can evaluate the effects of macrophages on the 
dynamics of cancer cell migration in a more physiologically relevant environment than 2D 
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in vitro assays. In addition, this microfluidic assay is better suited for the detailed 
mechanistic study of macrophage-assisted cancer cell migration than in vivo assays (such as 
intravital imaging), as it is easier to operate and offers a tightly controlled experimental 
environment. Using this microfluidic assay, we show that macrophages release TNFα and 
TGFβ1 that increase both migration speed (total speed) and persistence (directedness) of 
cancer cells in 3D ECM. Interestingly, macrophage-released TNFα and TGFβ1 were found 
to promote cancer cell migration speed and persistence through two different mechanisms. 
Specifically, macrophages enhance cancer cell migration speed mainly through TGFβ1-
induced MT1-MMP expression in cancer cells. In comparison, macrophage-released TNFα 
and TGFβ1 synergistically enhance cancer cell migration persistence via NF-κB-dependent 
MMP1 expression. These results demonstrate, for the first time, that speed and persistence 
of cancer cell migration in 3D can be modulated by macrophages via different pathways, 
which strongly suggests that both of these pathways need to be targeted to effectively 
mitigate macrophage-induced metastasis.
Methods
Cell culture and reagents
MDA-MB-231 human breast carcinoma cells expressing GFP (MDA231) were kindly 
provided by Dr. Frank Gertler, MIT. PC3 human prostate carcinoma cells (PC3), MDA-
MB-435S human melanoma cells (MDA435), and Raw 264.7 mouse macrophages (Raw) 
were obtained from American Type Culture Collection. MDA231, MDA435, and Raw cells 
were cultured in DMEM. PC3 were cultured in RPMI. All media were supplemented with 
10% fetal bovine serum (FBS), and 100 U/mL penicillin/streptomycin. Cell lines were 
authenticated using Short Tandem Repeat profiling (Promega).
To generate primary bone marrow-derived macrophages (BMDM), bone marrow cells were 
first isolated from the femurs of C57BL/6 mice. These cells were then differentiated in 
RPMI supplemented with 10% FBS, 1% HEPES, 40 ng/mL MCSF (Peprotech) and 50 µM 
β-Mercaptoethanol for 7 days to produce BMDM. Primary human monocyte-derived 
macrophages (MDMΦ) were generated from monocytes isolated from whole blood 
(Research Blood Component) using a Ficoll-Paque gradient and the EasySep™ Monocyte 
Enrichment Kit (StemCell Tech.). These cells were cultured with IMDM supplemented with 
2% L-glutamine and AB serum for 7 days to generate MDMΦ. All cells were cultured in a 
humidified incubator at 5% CO2 and 37 °C.
Microfluidic 3D cell migration assay
To quantify macrophage-assisted cancer cell migration in 3D ECM, a microfluidic cell 
migration assay was used (Fig. 1A and Fig. S1A in supplementary information, SI). This 
assay consists of a polydimethylsiloxane (PDMS) microfluidic device (20) with a collagen 
gel flanked by two micro-channels containing media. 2.3×106 cells/mL of cancer cells 
and/or 0.92×106 cells/mL of macrophages treated with Cell Tracker Red CMTPX were 
suspended in 2.5 mg/mL rat-tail collagen type I ECM (BD Bioscience) introduced to the 
central chamber of the device. For a detailed description of seeding protocols, see SI.
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After overnight incubation, the microfluidic device was transferred to a fluorescent 
microscope (Zeiss) fitted with an environmental chamber operating at 37 °C and 5% CO2. 
Time-lapse microscopy was employed to record cancer cell movement in the 3D collagen I 
ECM. Images were taken every 15 mins for 18 hrs.
ImageJ (NIH) was used to track cancer cell movement to produce cell migration trajectories. 
The migration trajectories were analyzed with Chemotaxis and Migration software (Ibidi) to 
quantify the dynamics of cell migration such as total speed and directedness. Total speed 
was calculated as total distance the cell travelled divided by migration time, while 
directedness was calculated as the displacement of the cell divided by total distance (Fig. 
S1B).
As appropriate, various concentrations of neutralizing antibodies, inhibitors, or recombinant 
growth factors (listed in SI) were added to the cell culture media in the device.
Real-time PCR and western blot analysis
Total RNA was extracted and purified using the RNeasy Mini Kit and RNase-free DNase Set 
(QIAGEN). Expression levels of mRNA were analyzed by real-time RT-PCR using High 
Capacity RNA-to-cDNA Kit and SYBR Green Master Mixture (Applied Biosystems). The 
sequences of the primers used can be found in SI. Data were analyzed according to the 
comparative Ct method and were normalized to GAPDH expression in each sample.
Cell lysate was extracted with RIPA buffer containing protease inhibitor and PMSF. Equal 
amount of total protein (30 µg) was resolved on 4–12% NuPAGE electrophoresis gels 
(Invitrogen) and transferred onto nitrocellulose membranes. The membranes were probed 
with various primary antibodies listed in SI, followed by secondary antibodies conjugated to 
horseradish peroxidase. The immunoreactive bands were detected with ECL 
Chemiluminescent substrates. Densitometry analysis was performed using Alpha Innotech 
software to quantify western blot images. The densitometry quantification for each protein 
was normalized to the appropriate loading control (β-actin, GAPDH, Lamin B1) before 
further normalized to the control group of each experiment.
Statistical analysis
All statistical analyses were performed using GraphPad Prism with a P-value of <0.05 
considered statistically significant. The difference between groups was evaluated by two-
tailed student t-test or one-way ANOVA. In all figures, ns represents not significant, * 
represents p<0.05, ** represents p<0.01, and *** represents p<0.001. For cell migration 
quantification, bars represent mean ± standard error of mean (SEM) of data from 40–100 
cells from 3 independent experiments. For western blot and qRT-PCR quantification, bars 
represent mean ± SEM of data (fold increase relative to no-treatment or mono-culture 
control) from 3 independent experiments.
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Results
Macrophages enhance cancer cell migration total speed and directedness in 3D ECM
To determine the effects of macrophages on the dynamics of cancer cell migration in 3D 
matrix, we tracked the movement of cancer cells inside the collagen I ECM in the 
microfluidic devices. We chose to use collagen I ECM to mimic the tumor matrix since 
collagen I has been shown to be the major component of tumor-associated stromal tissue 
(3,21) and it has also been implicated in metastasis (22). From the cell tracking, we 
quantified cancer cell migration total speed and directedness (defined in Fig. S1B), and we 
compared the migration dynamics of cancer cells cultured alone to that of cancer cells co-
cultured with Raw macrophages (Fig.1B and Fig. S1C). We found that Raw macrophages 
significantly enhanced cancer cell migration total speed and directedness (Fig. 1C–D) in 3D 
ECM for MDA-MB-231, PC3, and MDA-MB-435S cells. Similar to Raw macrophages, 
primary macrophages such as human MDMΦ and murine BMDM were also observed to 
increase cancer cell migration total speed and directedness (Fig. 1E–F) in 3D ECM. These 
results indicate that macrophages allow cancer cells to move faster and more persistently, 
contributing to increases in cancer cell invasion rate (ratio between the displacement of cell 
and migration time), which is an end-point measurement of cell invasiveness (Fig. S2). 
These results are in stark contrast to results obtained from a 2D migration assay, where we 
found that macrophages only slightly enhanced cancer cell migration total speed but 
markedly reduced cancer cell migration directedness (Fig. S2F). Moreover, the abilities of 
macrophages to enhance cancer cell migration dynamics in 3D ECM were not affected by 
the seeding ratio of the cells or the addition of Matrigel into the collagen I ECM (Fig. S2G–
H). Hence, these results suggest that there are fundamental differences in how macrophages 
affect cancer cell migration on 2D substrates versus in 3D ECM.
Macrophage-induced cancer cell migration in 3D ECM is mediated via cancer cell MMP 
expression
Next, we investigated the molecular mechanisms that control how fast and how persistently 
the cancer cell migrates in 3D ECM. We hypothesized that MMPs produced by cancer cells 
are involved, since the migration of cells in the dense 3D matrix critically depends on their 
ability to degrade ECM (4,19). To test this hypothesis, we treated MDA231 cancer cells with 
a pan-MMP inhibitor GM6001. We found that inhibiting MMP activities in cancer cells 
significantly reduced cancer cell migration total speed and directedness (Fig. 2B–C). Further 
evidence for the role of MMPs was obtained using confocal reflectance microscopy, which 
revealed that the migration of MDA231 cells in ECM produced micro-tracks of empty space 
(Fig. 2A). However, when these cells were treated with GM6001, the formation of cell 
protrusions, as well as the ability of cells to degrade ECM, was reduced compared to control 
samples (Fig. S3A–B). These results illustrate that cancer cells migrate in our experimental 
system in an MMP-dependent fashion, and the production of MMPs is a critical determinant 
of cancer cell migration dynamics (total speed and directedness) in 3D ECM.
Based on these findings, we examined the role of macrophages in regulating MMP1 and 
MT1-MMP expression by cancer cells. We chose to study these two MMPs since these 
proteases are responsible for the breakdown of collagen I matrix. Moreover, MT1-MMP and 
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MMP1 have been shown to be present in the tumor microenvironment, and they have been 
implicated in tumor metastasis (23–27). To study how macrophages influence MMP 
expressions in cancer cells, we co-cultured cancer cells with macrophages in a transwell 
system, and assessed the cancer cell expression of MMP1 and MT1-MMP via western 
blotting. We found that co-culture of MDA231 cancer cells with Raw macrophages, as well 
as BMDM, significantly enhanced cancer cell expression of MMP1 and MT1-MMP (Fig. 
2D–E and S3C). This result was reproduced in PC3 prostate cancer cells co-cultured with 
macrophages (Fig. S3D).
Next, we tested whether it is necessary for macrophages to be in direct physical contact with 
cancer cells to promote migration. Instead of culturing Raw macrophages together with 
MDA231 cancer cells in the ECM, we cultured macrophages in the micro-channels flanking 
the ECM (Fig. S4A). The macrophages seeded in the micro-channels were not in physical 
contact with the ECM or the cancer cells, but they were able to communicate with the cancer 
cells via the secretion of paracrine factors. Interestingly, we found that macrophages cultured 
in the micro-channel increased cancer cell migration total speed and directedness to the 
same degree as macrophages cultured in the collagen ECM (Fig. S4B), suggesting that direct 
contact between macrophages and cancer cells is not necessary to enhance cancer cell 
migration. We also found that the conditioned media from Raw macrophages and BMDM 
significantly up-regulated the expression of MMP1 and MT1-MMP (Fig. S4C–G) in cancer 
cells. These results indicate that the effects of macrophages on cancer cell migration 
dynamics and MMP expressions are mediated primarily through paracrine factors secreted 
by macrophages.
Macrophage-released TNFα and TGFβ1 are responsible for the increases in cancer cell 
migration total speed and directedness
We next performed experiments to identify the paracrine factors released by macrophages 
that were responsible for the increases in cancer cell migration dynamics. We hypothesized 
that TNFα and TGFβ1 secreted by macrophages are involved in promoting cancer cell 
migration, since these two factors are major secretory products of macrophages in the tumor 
microenvironment (28–31), and they have been implicated in tumor metastasis (32,33). 
Indeed, primary macrophages such as MDMΦ and BMDM have been shown to secrete 
TNFα and TGFβ1 (34–37). We first verified, using ELISA, that Raw macrophages used in 
our study also secreted TNFα and TGFβ1 (Fig. S4H). To test our hypothesis further, we 
treated cancer cell-macrophage co-culture with neutralizing antibodies against TNFα and/or 
TGFβ1, and measured cancer cell migration total speed and directedness as before. The 
antibodies used in this study were designed to act against mouse TNFα and TGFβ1. This 
allowed us to specifically inhibit TNFα and TGFβ1 secreted by Raw 264.7 mouse 
macrophages. Antibody blocking results showed that neutralizing TNFα in co-culture 
slightly decreased macrophage-enhanced cancer cell migration total speed, while blocking 
TGFβ1 almost completely abrogated the effects of macrophages on total speed (Fig. 3A–B). 
Co-blocking both TNFα and TGFβ1 did not further reduce cancer cell migration total 
speed when compared to the blocking of only TGFβ1 (Fig. 3C). These results suggest that 
TGFβ1 is primarily responsible for the ability of macrophages to enhance cancer cell 
migration total speed.
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Surprisingly, when we assessed the effects of antibody blocking on cancer cell migration 
directedness, we found that inhibiting either TNFα or TGFβ1 in co-culture did not lead to 
significant decreases in cancer cell migration directedness (Fig. 3D–E). In contrast, blocking 
TNFα and TGFβ1 simultaneously almost completely abolished the ability of macrophages 
to promote migration directedness (Fig. 3F), suggesting that both TNFα and TGFβ1 are 
important to macrophage-enhanced migration directedness. Interestingly, this result is in 
contrast to the antibody blocking results for total speed, which seems to suggest that 
macrophage-enhanced cancer cell migration total speed and directedness are controlled by 
two different pathways. Finally, to verify if blocking antibody treatments were specific to 
macrophage-secreted TNFα and TGFβ1, we treated cancer cell monocultures with anti-
mouse neutralizing antibodies that we used in co-culture experiments. We found this to have 
no significant effect on MDA231 cell migration total speed and directedness (Fig. S5), 
indicating that the antibody inhibition was macrophage-specific.
We next demonstrated that co-blocking of both TNFα and TGFβ1 in co-culture resulted in 
almost complete inhibition of macrophage-induced MMP1 and MT1-MMP protein 
expression in cancer cells (Fig. S6A–B). These results further support our previous 
conclusion that macrophage-enhanced cancer cell migration total speed and directedness in 
3D ECM are controlled by MMPs. Finally, as expected, since both migration total speed and 
directedness contribute to cancer cell invasion rate (Fig. S2), blocking of TNFα or TGFβ1 
cannot completely abrogate macrophage-enhanced cancer cell invasion rate. In contrast, 
when both macrophage TNFα and TGFβ1 were inhibited, cancer cell invasion rate in co-
culture was reduced to the level of the cancer cell monoculture control (Fig. S6C).
Macrophage-released TGFβ1 enhances cancer cell migration total speed via MT1-MMP, 
while macrophage-released TNFα and TGFβ1 synergistically increase cancer cell 
migration directedness via MMP1
We then proceeded to examine the detailed mechanisms by which macrophage-released 
TNFα and TGFβ1 affect cancer cell migration dynamics. We also sought to elucidate the 
seemingly distinct pathways that are involved in promoting migration total speed and 
directedness. Since it is difficult to perform a detailed and well-controlled study on 
molecular mechanism with blocking antibodies alone, we elected to treat cancer cell 
monocultures with TNFα and/or TGFβ1 and assess the resulting cell migration dynamics 
and MMP expressions. We found that the treatment of MDA231 cancer cell with TNFα 
slightly increased cancer cell migration total speed, while TGFβ1 treatment significantly 
enhanced total speed. No additional increase in migration total speed was observed for 
TNFα and TGFβ1 co-treatment over the TGFβ1 mono-treatment condition (Fig. 4A). These 
results parallel the blocking antibody experiments and further support our prior conclusion 
that macrophage-released TGFβ1 is the main contributor to the increase in cancer cell 
migration total speed.
In contrast to its effects on total speed, TNFα or TGFβ1 mono-treatment did not 
significantly enhance cancer cell migration directedness. When the cancer cells were treated 
with both TNFα and TGFβ1, however, there was a synergistic increase in cancer cell 
migration directedness that cannot be explained by the additive effects of TNFα and TGFβ1 
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mono-treatment (Fig. 4D). Combined, these results provide further evidence that 
macrophage-induced cancer cell 3D migration total speed and directedness are controlled by 
two distinct mechanisms. Specifically, cancer cell migration total speed is controlled 
primarily by macrophage-released TGFβ1, while the directedness is controlled by the 
combined effects of macrophage-released TNFα and TGFβ1. Finally, we found that co-
treatment of cancer cell monoculture with TNFα and TGFβ1 led to levels of migration total 
speed and directedness (Fig. S7) comparable to those in co-culture, indicating that TNFα 
and TGFβ1 from macrophages are, indeed, the main factors responsible for the enhancement 
in cancer cell migration.
For further verification that cancer cell migration total speed and directedness are controlled 
through two distinct pathways, we varied the concentration of TNFα and TGFβ1 in the co-
treatment condition. Specifically, we treated MDA231 cancer cells with 5 ng/mL TNFα 
+ 0.5 ng/mL TGFβ1, or 0.5 ng/mL TNFα + 5 ng/mL TGFβ1, or 5 ng/mL TNFα + 5 ng/mL 
TGFβ1. Interestingly, treating cancer cells with a low concentration of TGFβ1 (0.5 ng/mL), 
even in the co-treatment conditions, resulted in slight or no increase in the migration total 
speed (Fig. S8A). These results further illustrate that cancer cell migration total speed is 
mainly controlled by TGFβ1. In comparison, treating cancer cells with various 
concentrations of TNFα or TGFβ1 in the co-treatment regimen resulted in similar levels of 
increase in cancer cell migration directedness over the no-treatment control. Moreover, 
addition of even a minute amount (0.5 ng/mL) of TGFβ1 to TNFα mono-treatment resulted 
in sharp increases in cancer cell migration directedness. A similar response was observed 
when a minute amount of TNFα (0.5 ng/mL) was added to TGFβ1 mono-treatment (Fig. 
S8B). These results further verify that TNFα and TGFβ1 synergistically enhance cancer cell 
migration directedness.
Since cancer cell migration in 3D ECM depends on the cell’s ability to express MMPs, it 
seemed that the effects of TNFα and TGFβ1 on cancer cell migration dynamics might also 
be mediated through MMPs. To test for this hypothesis, we treated MDA231 monoculture 
with TNFα and/or TGFβ1 and evaluated the resulting MMP1 and MT1-MMP mRNA and 
protein expression. We found that the treatment of cancer cells with TNFα resulted in a 
slight increase in MT1-MMP mRNA and protein expression. In comparison, the treatment of 
cells with TGFβ1 alone markedly enhanced MT1-MMP mRNA and protein expression, 
while co-treatment of both TNFα and TGFβ1 led to no further increase in MT1-MMP 
expressions (Fig. 4B–C). We noted that these trends in the increases in MT1-MMP mRNA 
and protein expressions match the trend in the increases in cancer cell migration total speed 
(Fig. 4A). This observation points to the possibility that TGFβ1-induced increase in cell 
migration total speed is mediated mainly via MT1-MMP. Furthermore, we observed that 
TNFα and TGFβ1 synergistically enhanced cancer cell expression of MMP1 mRNA and 
protein (Fig. 4E–F). These findings are similar to the observation that TNFα and TGFβ1 
synergistically promote cancer cell migration directedness (Fig. 4D), suggesting that TNFα/
TGFβ1-induced cancer cell migration directedness is mediated mainly by MMP1 
expression. Indeed, Pearson correlation analysis revealed that MT1-MMP expression levels 
resulting from TNFα and/or TGFβ1 treatments strongly correlate with cancer cell migration 
total speed, but not directedness Similarly, MMP1 expression levels in cancer cells strongly 
correlate with migration directedness, but not total speed (Fig. S9). These results led us to 
Li et al. Page 8
Cancer Res. Author manuscript; available in PMC 2018 January 15.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
hypothesize that macrophage-induced cancer cell migration total speed is controlled by 
MT1-MMP expression in cancer cells, while the directedness is controlled by MMP1 
expression.
To test whether or not macrophage-induced cancer cell migration total speed and 
directedness are controlled by two different MMPs, we treated cancer cell-macrophage co-
culture with blocking antibodies against MT1-MMP and MMP1. We found that treating the 
co-culture with anti-MT1-MMP antibody resulted in a significant decrease in cancer cell 
migration total speed with little effect on directedness (Fig. 5A–B). In contrast, we observed 
that blocking MMP1 in co-culture with anti-MMP1 antibody had almost no effect on 
macrophage-induced increase in cancer cell migration total speed, while the increase in 
cancer cell migration directedness was significantly reduced (Fig. 5C–D). Furthermore, we 
treated cancer cell monoculture with exogenously supplied recombinant MMP1 and 
observed an enhancement in cancer cell migration directedness but no significant change in 
migration total speed (Fig. 5E–F). These findings, coupled with previous observations that 
macrophage-released TNFα and TGFβ1 up-regulated cancer cell expression of MMPs (Fig 
S6), strongly support the conclusion that macrophage-induced MMP1 expression is 
responsible for the increase in cancer cell migration directedness, while the induction of 
MT1-MMP expression is responsible for the increase in total speed. Taken together, these 
results (Fig. 3–5) demonstrate that macrophages influence cancer cell migration in 3D ECM 
via two different mechanisms: 1) macrophage-released TGFβ1 increase cancer cell 
migration total speed (speed) via the up-regulation of MT1-MMP expression, and 2) 
macrophage-released TNFα and TGFβ1 synergistically enhance cancer cell migration 
directedness (persistence) through the induction of MMP1 expression. Hence, these results 
strongly suggest that both of these two pathways need to be inhibited in order to effectively 
reduce metastasis. Indeed, using a 4T1 orthotopic breast tumor model in BALB/c mice, we 
found that inhibiting both TNFα and TGFβ1 in these mice resulted in a more significant 
reduction in lung metastasis formation compared to inhibiting TNFα or TGFβ1 alone (Fig. 
S10).
Finally, we found a similar synergistic response in MMP1 secretion due to TNFα and 
TGFβ1 co-treatment (Fig. S11A), which mirrors the results of cancer cell migration 
directedness (Fig. 4D). The synergistic induction in MMP1 protein production was also 
observed in MDA435 and PC3 cells (Fig. S11B–C).
TNFα and TGFβ1 synergistically increase nuclear localization of NF-κB
To further understand the synergistic effects of TNFα and TGFβ1 on the expression of 
MMP1 in cancer cells, we tested whether TNFα and/or TGFβ1 could alter the expression or 
nuclear localization of NF-κB, a transcription factor for MMP1 (38). We first treated 
MDA231 cancer cells with TNFα and/or TGFβ1 for 48 hrs, and found that these two factors 
did not change the protein production of NF-κB by cancer cells (Fig. 6A). We then tested 
whether the treatment of these two factors could alter the nuclear localization of NF-κB. 
Indeed, co-treatment of TNFα and TGFβ1 synergistically enhanced NF-κB expression 
inside the nucleus of the cancer cells (Fig. 6B–C). These results support the conclusion that 
TNFα and TGFβ1 act together to enhance the expression of MMP1 via the synergistic 
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induction of NF-κB nuclear translocation. Similar results were also observed in MDA435 
cells (Fig. S12).
Discussion
Macrophages in the tumor microenvironment are key promoters of cancer cell metastasis 
(8), suggesting that the control of these cells and their released factors can be a viable 
strategy in treating metastasis. Yet, it is still unclear how macrophages affect different 
aspects of cancer cell migration, such as speed and persistence, especially in 3D ECM that 
closely mimics the in vivo tumor microenvironment. To address this gap in knowledge, we 
utilized a microfluidic 3D cell migration assay that allows us to study, in high resolution, the 
effects of macrophages on cancer cell migration speed (total speed) and persistence 
(directedness) in 3D ECM.
From our study, we found that macrophages increase cancer cell migration speed and 
persistence in 3D collagen I ECM, suggesting that macrophages may help cancer cells 
invade and gain access to intravasation sites more efficiently. In contrast to the 3D results, 
we discovered that on 2D tissue culture plastic, macrophages tend to increase cancer cell 
migration speed but decrease persistence, so that cancer cells move faster, but more 
randomly. This disparity, similar to results obtained from previous works, illustrates a 
fundamental difference in how cancer cells migrate in 2D compared to 3D (19). We also 
note that the cancer cells in our 3D microfluidic system migrated at a total speed of 5–11 
µm/hr, a value which closely matches the speed values obtained from in vivo intravital 
imaging experiments (39). In sum, these results demonstrate the advantages of our 
microfluidic assay, which allows us to perform physiologically relevant studies with precise 
control of experimental conditions.
In 3D, cell migration critically depends on the ability of cancer cells to degrade ECM. 
Indeed, MMP expression is dispensable for 2D cell migration, but not for 3D (19). In the 
present study, we showed that macrophages enhanced cancer cell migration in 3D ECM via 
the up-regulation of MMP expression in cancer cells. We further identified that macrophage-
released TGFβ1 increased cancer cell migration speed, while macrophage-released TNFα 
and TGFβ1 synergistically enhanced cancer cell migration persistence. Previous studies 
have shown that EGF released by macrophages can promote cancer cell migration (14). 
Here, we report that macrophage-released TNFα and TGFβ1 can also promote cancer cell 
migration. The clinical relevance of this finding is demonstrated by the fact that the 
expression levels of TNFα and TGFβ1 in tumor-associated macrophages correlates with 
metastasis for human tumors (28,40). Moreover, this study, to our knowledge, is the first to 
report that macrophage-released TNFα and TGFβ1 control different aspects of cancer cell 
migration (speed vs. persistence) differently. Thus, although prior studies have implicated 
TNFα and TGFβ1 in cancer cell invasion and metastasis (32,33), our results now 
demonstrate subtle but important differences in their effects on cancer cell migration.
We also found that TGFβ1 released by macrophages promotes cancer cell migration speed 
through up-regulation of MT1-MMP. We suspect this is due to the fact that MT1-MMP can 
influence cell intrinsic migration behaviors as well as cell extrinsic matrix properties, both of 
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which are known determinants of cell migration speed in 3D matrix (19,41). Two examples 
of cell intrinsic behaviors that control cell migration speed are the activities of kinases and 
the expression of integrin. It has been shown that intermediate levels of integrin α2β1 
contribute to an optimum cell migration speed (42,43); and inhibiting integrin could lead to 
a decrease in cell migration speed, but not persistence (17). Similarly, inhibiting Akt/PI3K 
activities in cells has been reported to result in a decrease in migration speed (44). In 
addition to cell intrinsic properties, cell extrinsic matrix properties, such as the pore size of 
the matrix that can be modified by MMPs, also affect cell migration speed in 3D (41). 
Unlike MMP1, which primarily degrades collagen I matrix to alter the cell extrinsic 
properties, MT1-MMP modifies both cell intrinsic and cell extrinsic properties. Besides 
degrading collagen I matrix, MT1-MMP can process integrin (45), mediate Akt 
phosphorylation (46), and promote syndecan shedding (47), all of which are parts of cell 
intrinsic pathways of migration. Hence, since both intrinsic and extrinsic properties control 
cell migration speed, it stands to reason that MT1-MMP should be the major determinant of 
migration speed over MMP1.
We further demonstrated that macrophage-enhanced cancer cell migration persistence, in 
contrast to total speed, was mediated primarily by the expression of MMP1, but not MT1-
MMP. This result may be explained by the fact that MMP1 is more efficient in degrading 
collagen I matrix and altering extrinsic matrix properties (pore size) than MT1-MMP (48). 
Although cell intrinsic properties (such as Rac activities (49)) control migration persistence 
in 2D, it has been reported that cell extrinsic matrix properties seem to dominate over 
intrinsic property as the primary determinant of 3D migration persistence (19,50). Since 
MMP1 is more efficient in degrading collagen I ECM and altering extrinsic matrix 
properties than MT1-MMP, MMP1 should therefore be a major contributor to migration 
persistence.
Based on our findings, we propose a novel mechanism whereby macrophages promote 
cancer cell migration speed (total speed) and persistence (directedness) via two distinct 
mechanisms (Fig. 7). First, macrophage-released TNFα and TGFβ1 synergistically induce 
nuclear translocation of NF-κB in cancer cells, leading to synergistic increases in the 
expressions of MMP1, which result in a synergistic enhancement in cancer cell migration 
persistence. In contrast to the mechanism for the persistence, macrophages increase cancer 
cell migration speed, mainly through TGFβ1, by the up-regulation of cancer cell MT1-MMP 
expression. These findings establish that TNFα and TGFβ1 released by macrophages 
influence speed and persistence of cancer cell migration differently, and both of these factors 
need to be targeted to effectively inhibit macrophage-assisted cancer cell 3D migration and 
metastasis. Moreover, these findings also broaden our current view on the molecular 
determinants of 3D migration, suggesting that MT1-MMP primarily controls cell migration 
speed, whereas MMP1 mainly controls migration persistence. In conclusion, our findings 
provide new insights into macrophage-assisted cancer cell migration in 3D tumor 
microenvironment, and these could ultimately lead to novel therapeutic strategies to 
effectively inhibit tumor invasion and metastasis.
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Figure 1. Macrophages enhance cancer cell migration total speed and directedness in 3D ECM
(A) Schematics of the microfluidic device. Cancer cells and macrophages were suspended in 
3D collagen I ECM (orange) encased in the device. (B) Representative MDA-MB-231 
cancer cell (MDA231) migration trajectories for cancer cell monoculture (left) and cancer 
cell-Raw 264.7 macrophages (MΦ) co-culture (right). (C and D) Co-culture of Raw 
macrophages (MΦ) with cancer cells significantly enhanced cancer cell migration total 
speed (C) and directedness (D) for MDA231 cells, PC3 prostate cancer cells, and MDA-
MB-435S melanoma cells (MDA435). (E and F) Co-culture of primary human monocyte-
derived macrophages (MDMΦ), as well as murine bone marrow-derived macrophages 
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(BMDM), with MDA231 cells enhanced migration total speed (E) and directedness (F) of 
MDA231 cells.
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Figure 2. Cancer cell migration speed and directedness are MMP-dependent, and macrophages 
enhance cancer cell MMP expression
(A) Representative confocal image showing MDA231 cells (green) migrating through dense 
collagen I ECM (magenta) by degrading the matrix, leaving behind a micro-track (arrow). 
(B and C) Compared to the untreated and DMSO controls, inhibition of MMP activity by 
GM6001 significantly reduced MDA231 migration total speed (B) and directedness (C). (D 
and E) Representative western blot images (left) and quantification (right) showing that co-
culture of Raw macrophages with MDA231 cells (MDA231 Cocul) in 3D collagen I gels 
significantly enhanced the expression of MMP1 (D) and MT1-MMP protein (E) in MDA231 
relative to monoculture control (MDA231, Ctrl=Control).
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Figure 3. Macrophage-released TNFα and TGFβ1 are responsible for the increase in cancer cell 
migration total speed and directedness
MDA231 cancer cells (CC) co-cultured with Raw cells (MΦ) were treated with neutralizing 
antibodies against TNFα (a-TNFα) and/or TGFβ1 (a-TGFβ1). (A, B, and C) Neutralizing 
TNFα released by macrophages (CCMΦ a-TNFα) led to a decrease in MDA231 migration 
total speed compared to no-treatment control (CCMΦ) (A). However, inhibiting 
macrophage-released TGFβ1 (CCMΦ a-TGFβ1) led to an almost complete inhibition of 
macrophage’s effect on MDA231 migration total speed (B), similar to the simultaneous 
inhibition of both TNFα and TGFβ1 (C). (D, E, and F) Neutralizing macrophage-released 
TNFα (CCMΦ a-TNFα) or TGFβ1 (CCMΦ a-TGFβ1) alone did not significantly reduce 
MDA231 migration directedness (D and E). However, simultaneous inhibition of both 
TNFα and TGFβ1 led to an almost complete abolishment of macrophage-enhanced 
MDA231 migration directedness (F).
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Figure 4. TGFβ1 increases cancer cell migration total speed via the induction of MT1-MMP 
expression, while TNFα and TGFβ1 synergistically increase cancer cell migration directedness 
via the induction of MMP1 expression
MDA231 monoculture (CC) was treated with TNFα and/or TGFβ1, and the resulting cell 
migration dynamics and MMP expressions were analyzed. (A–C) Treatment of MDA231 
with TGFβ1 (CC TGFβ1) led to larger increases in MDA231 migration total speed (A), 
MT1-MMP mRNA (B) and protein (C) expressions than TNFα mono-treatment (CC 
TNFα). However, co-treatment of both TNFα and TGFβ1 led to no further increase in 
migration total speed, MT1-MMP mRNA and protein expressions compared to TGFβ1 
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mono-treatment. Data in (A), (B), and (C) follow a similar trend. (D–F) TNFα and TGFβ1 
synergistically increased MDA231 migration directedness (D), MMP1 mRNA expression 
(E), and MMP1 protein production (F) when compared to mono-treatment conditions. Data 
in (D), (E), and (F) follow a similar trend. Data in (C) and (F) were obtained from cells 
cultured in 3D collagen I ECM.
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Figure 5. Macrophage-induced cancer cell migration total speed is mediated via MT1-MMP, 
while directedness is mediated by MMP1
MDA231 cancer cells (CC)-Raw macrophages (MΦ) co-culture was treated with blocking 
antibodies against MT1-MMP or MMP1. (A and B) Treatment of co-culture with anti-MT1-
MMP antibody (CCMΦ a-MT1-MMP) decreased MDA231 migration total speed (A) but 
not directedness (B). (C and D) Treatment of co-culture with anti-MMP1 antibody (CCMΦ 
a-MMP1) reduced MDA231 migration directedness (D) while having a minimal effect on 
total speed (C). (E and F) Treatment of MDA231 cancer cell monoculture with recombinant 
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MMP1 (CC MMP1) enhanced MDA231 migration directedness (F), while having a minimal 
effect on total speed (E).
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Figure 6. TNFα and TGFβ1 synergistically increase NF-κB nuclear localization
(A) Western blot quantification (top) and representative images (bottom) showing 48-hr 
TNFα and/or TGFβ1 treatments of MDA231 cells did not alter the production of NF-κB 
(NF-κB total). (B and C) Western blot quantifications (top) and representative images 
(bottom) showing 2-hr TNFα and TGFβ1 co-treatment of MDA231 synergistically 
increased the level of NF-κB in the nuclear fraction of MDA231 (NF-κB Nuc, C), but not in 
the cytoplasmic fraction of the cells (NF-κB Cyto, B).
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Figure 7. Proposed mechanism explaining the effects of macrophages (MΦ) on cancer cell (CC) 
migration speed and persistence
Macrophage-released TNFα and TGFβ1 synergistically enhance NF-κB nuclear localization 
in cancer cells, leading to synergistic increases in cancer cell MMP1 mRNA expression, 
protein production, and protein secretion. This increase in MMP1 secretion by cancer cells 
leads to an increase in cancer cell migration persistence (directedness). Meanwhile, 
macrophages increase cancer cell migration speed (total speed), mainly through TGFβ1-
induced cancer cell expression of MT1-MMP.
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